Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti Cancer Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Patent CN115261896B reveals electrochemical synthesis for high-purity intermediates. Offers cost reduction and supply chain reliability for anticancer drug manufacturing.
Patent CN112480015B details a Pd-catalyzed carbonylation method for quinazolinones. Offers high yield, mild conditions, and scalable routes for API intermediates.
Novel Pd-catalyzed route for C-3 benzyl indolizines offers high yield and operational simplicity for reliable pharmaceutical intermediate supply chains.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN112979529A discloses a novel one-step synthesis for aromatic amine indole naphthoquinone derivatives, offering significant cost reduction in API manufacturing and simplified supply chains.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Novel Curtius rearrangement route for pyrrolo[1,2-A]quinoxalin-4(5H)-one. High purity, scalable pharma intermediate synthesis avoiding toxic reagents.
Novel rhodium-catalyzed one-step synthesis offers high selectivity and cost reduction for pharmaceutical intermediate manufacturing supply chains ensuring reliable high-purity API precursor availability.
Novel copper-catalyzed oxidative cyclization route for indolo[3,2-c]quinoline derivatives offers cost-effective API intermediate manufacturing with superior scalability and purity.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity against QGP-1 cells.
Patent CN1712399B details a novel hybrid synthesis of paclitaxel-MDP conjugates improving solubility and efficacy. Discover cost-effective manufacturing strategies for advanced API intermediates.
Patent CN112480015A reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and safety improvements for API manufacturing.
Patent CN112209947A discloses a mild, high-yield organocatalytic route to chiral indoxazinones with potent anticancer activity, offering significant cost reduction in API manufacturing.